BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 27842593)

  • 1. Easy regulation of metabolic flux in Escherichia coli using an endogenous type I-E CRISPR-Cas system.
    Chang Y; Su T; Qi Q; Liang Q
    Microb Cell Fact; 2016 Nov; 15(1):195. PubMed ID: 27842593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering Halomonas species TD01 for enhanced polyhydroxyalkanoates synthesis via CRISPRi.
    Tao W; Lv L; Chen GQ
    Microb Cell Fact; 2017 Apr; 16(1):48. PubMed ID: 28381263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cas3 is a limiting factor for CRISPR-Cas immunity in Escherichia coli cells lacking H-NS.
    Majsec K; Bolt EL; Ivančić-Baće I
    BMC Microbiol; 2016 Mar; 16():28. PubMed ID: 26956996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cas3-stimulated runaway replication of modified ColE1 plasmids in Escherichia coli is temperature dependent.
    Radovčić M; Čulo A; Ivančić-Baće I
    FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31095294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining CRISPR and CRISPRi Systems for Metabolic Engineering of E. coli and 1,4-BDO Biosynthesis.
    Wu MY; Sung LY; Li H; Huang CH; Hu YC
    ACS Synth Biol; 2017 Dec; 6(12):2350-2361. PubMed ID: 28854333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of CRISPRi for prokaryotic metabolic engineering involving multiple genes, a case study: Controllable P(3HB-co-4HB) biosynthesis.
    Lv L; Ren YL; Chen JC; Wu Q; Chen GQ
    Metab Eng; 2015 May; 29():160-168. PubMed ID: 25838211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering cell wall synthesis mechanism for enhanced PHB accumulation in E. coli.
    Zhang XC; Guo Y; Liu X; Chen XG; Wu Q; Chen GQ
    Metab Eng; 2018 Jan; 45():32-42. PubMed ID: 29174524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR interference-guided multiplex repression of endogenous competing pathway genes for redirecting metabolic flux in Escherichia coli.
    Kim SK; Seong W; Han GH; Lee DH; Lee SG
    Microb Cell Fact; 2017 Nov; 16(1):188. PubMed ID: 29100516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycine Cleavage System and cAMP Receptor Protein Co-Regulate CRISPR/
    Yang D; Wang Z; Ma J; Fu Q; Wu L; Wang H; Wang S; Yan Y; Sun J
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31941083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cas3-Derived Target DNA Degradation Fragments Fuel Primed CRISPR Adaptation.
    Künne T; Kieper SN; Bannenberg JW; Vogel AI; Miellet WR; Klein M; Depken M; Suarez-Diez M; Brouns SJ
    Mol Cell; 2016 Sep; 63(5):852-64. PubMed ID: 27546790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPathBrick: Modular Combinatorial Assembly of Type II-A CRISPR Arrays for dCas9-Mediated Multiplex Transcriptional Repression in E. coli.
    Cress BF; Toparlak ÖD; Guleria S; Lebovich M; Stieglitz JT; Englaender JA; Jones JA; Linhardt RJ; Koffas MA
    ACS Synth Biol; 2015 Sep; 4(9):987-1000. PubMed ID: 25822415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering.
    Cho S; Shin J; Cho BK
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlling Citrate Synthase Expression by CRISPR/Cas9 Genome Editing for n-Butanol Production in Escherichia coli.
    Heo MJ; Jung HM; Um J; Lee SW; Oh MK
    ACS Synth Biol; 2017 Feb; 6(2):182-189. PubMed ID: 27700055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Transcriptional Repression in Bacteria Using CRISPR Interference (CRISPRi).
    Hawkins JS; Wong S; Peters JM; Almeida R; Qi LS
    Methods Mol Biol; 2015; 1311():349-62. PubMed ID: 25981485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different genome stability proteins underpin primed and naïve adaptation in E. coli CRISPR-Cas immunity.
    Ivančić-Baće I; Cass SD; Wearne SJ; Bolt EL
    Nucleic Acids Res; 2015 Dec; 43(22):10821-30. PubMed ID: 26578567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR interference-guided balancing of a biosynthetic mevalonate pathway increases terpenoid production.
    Kim SK; Han GH; Seong W; Kim H; Kim SW; Lee DH; Lee SG
    Metab Eng; 2016 Nov; 38():228-240. PubMed ID: 27569599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redirecting Metabolic Flux via Combinatorial Multiplex CRISPRi-Mediated Repression for Isopentenol Production in Escherichia coli.
    Tian T; Kang JW; Kang A; Lee TS
    ACS Synth Biol; 2019 Feb; 8(2):391-402. PubMed ID: 30681833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput determination of in vivo DNA sequence preferences for Cas protein binding using Library-ChIP.
    Wade JT
    Methods Enzymol; 2019; 616():117-132. PubMed ID: 30691640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric positioning of Cas1-2 complex and Integration Host Factor induced DNA bending guide the unidirectional homing of protospacer in CRISPR-Cas type I-E system.
    Yoganand KN; Sivathanu R; Nimkar S; Anand B
    Nucleic Acids Res; 2017 Jan; 45(1):367-381. PubMed ID: 27899566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.